ETOPOSIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for etoposide and what is the scope of patent protection?
Etoposide
is the generic ingredient in four branded drugs marketed by Mylan, Strides Pharma, Accord Hlthcare, Dash Pharms, Dash Pharms Natco, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, Watson Labs Inc, Corden Pharma, Bristol Myers Squibb, and Cheplapharm, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for etoposide. Five suppliers are listed for this compound.
Summary for ETOPOSIDE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 18 |
NDAs: | 20 |
Drug Master File Entries: | 11 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 1,601 |
Patent Applications: | 4,050 |
Drug Prices: | Drug price trends for ETOPOSIDE |
What excipients (inactive ingredients) are in ETOPOSIDE? | ETOPOSIDE excipients list |
DailyMed Link: | ETOPOSIDE at DailyMed |
Recent Clinical Trials for ETOPOSIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vanderbilt-Ingram Cancer Center | Phase 1/Phase 2 |
Genentech, Inc. | Phase 1/Phase 2 |
Vanderbilt-Ingram Cancer Center | Phase 2 |
Pharmacology for ETOPOSIDE
Drug Class | Topoisomerase Inhibitor |
Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for ETOPOSIDE
Anatomical Therapeutic Chemical (ATC) Classes for ETOPOSIDE
US Patents and Regulatory Information for ETOPOSIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Parenteral | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074510-001 | Jun 29, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074228-001 | Oct 15, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074320-001 | Aug 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Meitheal | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074529-001 | Jul 24, 1996 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ETOPOSIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Corden Pharma | VEPESID | etoposide | INJECTABLE;INJECTION | 018768-001 | Nov 10, 1983 | ⤷ Sign Up | ⤷ Sign Up |
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-002 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.